Joel L. Wherley - Aug 27, 2025 Form 3 Insider Report for CHEMED CORP (CHE)

Signature
Joel L Wherley
Stock symbol
CHE
Transactions as of
Aug 27, 2025
Transactions value $
$0
Form type
3
Date filed
8/27/2025, 01:16 PM
Next filing
Oct 22, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wherley Joel L CEO - Vitas Healthcare 255 EAST FIFTH STREET, SUITE 2600, CINCINNATI Joel L Wherley 2025-08-27 0002083070

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CHE Capital Stock 659 Aug 27, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CHE Stock Option (right to buy with tandem tax withholding) Aug 27, 2025 Capital Stock 6.96K $509.46 Direct F1
holding CHE Stock Option (right to buy with tandem tax withholding) Aug 27, 2025 Capital Stock 8.38K $597.70 Direct F2
holding CHE Performance Stock Unit Aug 27, 2025 Capital Stock 220 Direct F3, F4
holding CHE Performance Stock Unit Aug 27, 2025 Capital Stock 220 Direct F4, F5
holding CHE Performance Stock Unit Aug 27, 2025 Capital Stock 223 Direct F4, F6
holding CHE Performance Stock Unit Aug 27, 2025 Capital Stock 223 Direct F4, F7
holding CHE Performance Stock Unit Aug 27, 2025 Capital Stock 312 Direct F4, F8
holding CHE Performance Stock Unit Aug 27, 2025 Capital Stock 312 Direct F4, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting in three equal annual installments commencing 10/25/2024.
F2 Vesting in three equal annual installments commencing 10/22/2025.
F3 The restricted stock units vest based on the extent to which the Company achieves certain Earnings per Share performance targets over a performance period of January 1, 2023 through December 31, 2025 with the determination of such performance level to be made no later than March 15, 2026 and earned shares of Capital Stock to be delivered thereafter.
F4 Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock.
F5 The restricted stock units vest based on the extent to which the Company achieves certain Total Shareholder Return performance targets over a performance period of January 1, 2023 through December 31, 2025 with the determination of such performance level to be made no later than March 15, 2026 and earned shares of Capital Stock to be delivered thereafter.
F6 The restricted stock units vest based on the extent to which the Company achieves certain Earnings per Share performance targets over a performance period of January 1, 2024 through December 31, 2026 with the determination of such performance level to be made no later than March 15, 2027 and earned shares of Capital Stock to be delivered thereafter.
F7 The restricted stock units vest based on the extent to which the Company achieves certain Total Shareholder Return performance targets over a performance period of January 1, 2024 through December 31, 2026 with the determination of such performance level to be made no later than March 15, 2027 and earned shares of Capital Stock to be delivered thereafter.
F8 The restricted stock units vest based on the extent to which the Company achieves certain Earnings per Share performance targets over a performance period of January 1, 2025 through December 31, 2027 with the determination of such performance level to be made no later than March 15, 2028 and earned shares of Capital Stock to be delivered thereafter.
F9 The restricted stock units vest based on the extent to which the Company achieves certain Total Shareholder Return performance targets over a performance period of January 1, 2025 through December 31, 2027 with the determination of such performance level to be made no later than March 15, 2028 and earned shares of Capital Stock to be delivered thereafter.